Ion channels, receptors, agonists and antagonists

被引:0
|
作者
Weir, Cameron J. [1 ]
机构
[1] Ninewells Hosp & Med Sch, Anaesthetist, Dundee, Scotland
来源
关键词
G-protein-coupled receptors; inverse agonists; ligand-gated ion channels; voltage-gated ion channels;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This article describes the physiology of ion channels and the principal molecular mechanisms responsible for modulating their activity by commonly used drugs in anaesthesia and intensive care. The concept of efficient and selective transport of ions across 'impermeable' plasma membranes is introduced, together with the mechanisms influencing electro-chemical signalling within cells. The classification and composition of voltage-gated ion channels are described in the context of their contribution to action potential generation in excitable cells. Druge receptor interaction of the four main classes of receptor, that is, ligand-gated ion channels (in particular Cys-loop channels), G-protein-coupled, enzyme-linked and nuclear receptors, are described together with an overview of the various signal-transduction mechanisms adopted by metabotropic receptors to control cellular function. Finally, the principles of drugereceptor interaction of agonists, antagonists and inverse agonists are discussed in relation to their affinity, efficacy and potency.
引用
收藏
页码:410 / 416
页数:7
相关论文
共 50 条
  • [21] The agonist paradox: Agonists and antagonists of acetylcholine receptors and opioid receptors
    Dukhovich, FS
    Darkhovskii, MB
    Gorbatova, EN
    Polyakov, VS
    CHEMISTRY & BIODIVERSITY, 2005, 2 (03) : 354 - 366
  • [22] Agonists and antagonists of protease activated receptors (PARs)
    Barry, GD
    Le, GT
    Fairlie, DP
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (03) : 243 - 265
  • [23] Designing peptidomimetic antagonists for peptide receptors: topochemical differences of agonists and antagonists
    Hruby, VJ
    Liao, S
    Han, G
    Bonner, G
    Shenderovich, M
    Slaninova, J
    Porreca, F
    Yamamura, HI
    Hadley, ME
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 26 - 29
  • [24] Structures of the human cholecystokinin receptors bound to agonists and antagonists
    Zhang, Xuefeng
    He, Chenglin
    Wang, Mu
    Zhou, Qingtong
    Yang, Dehua
    Zhu, Ya
    Feng, Wenbo
    Zhang, Hui
    Dai, Antao
    Chu, Xiaojing
    Wang, Jia
    Yang, Zhenlin
    Jiang, Yi
    Sensfuss, Ulrich
    Tan, Qiuxiang
    Han, Shuo
    Reedtz-Runge, Steffen
    Xu, H. Eric
    Zhao, Suwen
    Wang, Ming-Wei
    Wu, Beili
    Zhao, Qiang
    NATURE CHEMICAL BIOLOGY, 2021, 17 (12) : 1230 - 1237
  • [25] Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
    Lattanzi, Roberta
    Miele, Rossella
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (12) : 6323 - 6332
  • [26] Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors
    Zlotos, D. P.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (21) : 3532 - 3549
  • [27] Opioid-agonists, -antagonists, and opioid-receptors
    Holzgrabe, U
    Nachtsheim, C
    Siener, T
    Drosihn, S
    Brandt, W
    PHARMAZIE, 1997, 52 (01): : 4 - 22
  • [28] INTERACTIONS OF AGONISTS AND ANTAGONISTS WITH BETA-ADRENERGIC RECEPTORS
    MOLINOFF, PB
    WEILAND, GA
    HEIDENREICH, KA
    PITTMAN, RN
    MINNEMAN, KP
    ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH, 1981, 14 : 51 - 67
  • [29] INTERACTION OF BENZODIAZEPINE AGONISTS AND ANTAGONISTS WITH DIFFERENT BENZODIAZEPINE RECEPTORS
    SIEGHART, W
    DREXLER, G
    MAYER, A
    SCHUSTER, A
    ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1983, 38 : 11 - 19
  • [30] QSPR analysis of some agonists and antagonists of α-adrenergic receptors
    Piotr Kawczak
    Leszek Bober
    Tomasz Bączek
    Medicinal Chemistry Research, 2015, 24 : 372 - 382